Results 151 to 160 of about 789,461 (263)

Positive surgical margins after robot-assisted radical prostatectomy Long-term oncologic consequences. [PDF]

Can Urol Assoc J
Malshy K, Jia Y, Cheng Z, Steidle M, Zhu D, Li A, Hunt TC, Sandoval V, Bandari J, Joseph JV.   +9 more
europepmc   +1 more source

Clinical Rationale of Dual‐Parameter Tumor Markers Reporting Without Reliance on Normal Reference Ranges

Journal of Clinical Laboratory Analysis, Volume 40, Issue 18, September 2026.
We recommend the current practice of tumor marker reporting to upgrade to two‐figure format to include a specific growth rate in parentheses. This can be of great clinical importance, especially in the subnormal range. ABSTRACT Introduction This review offers clinicians a novel view of tumor markers (TM).
Jurate Civinskaite, Daiva Gudaviciene, Gintaras Zaleskis, Aleksandras Petrauskas, Dainius Characiejus, Tatjana Ivaskiene   +5 more
wiley   +1 more source

Outcomes After Laparoscopic Radical Prostatectomy Versus da Vinci Robot-Assisted Laparoscopic Radical Prostatectomy. [PDF]

Cureus
Tejeda-Andrade C, Castro-Zazueta S, Galland-Novelo ME, Gomez-Regalado F, Figueroa-Garcia A, Ruiz-Guerrero LI, Vazquez-Villegas ML.   +6 more
europepmc   +1 more source

Optimal Selection of the Effective Echo Time (TEeff ) for T2‐Weighted Fast‐Spin‐Echo MRI of the Prostate at 3.0 T: Effect on Lesion Conspicuity

Journal of Magnetic Resonance Imaging, Volume 64, Issue 3, Page 616-628, September 2026.
ABSTRACT Background Clinical T 2‐weighted (T2W) MRI of prostate cancer (PCa) usually implements a 2D fast‐spin‐echo (FSE) sequence, but understanding the echo‐time‐dependent contrast behavior is not straightforward due to the complicated FSE signal evolution.
Dahan Kim, Ronard Pabi, Eric A. Borisch, Adam T. Froemming, Roger C. Grimm, Sara Hassanzadeh, Akira Kawashima, Ayumu Kido, Naoki Takahashi, John V. Thomas, Stephen J. Riederer   +10 more
wiley   +1 more source

From Operative-Time Prediction to Scheduling Utility in Robot-Assisted Radical Prostatectomy. [PDF]

Int J Urol
Chen Y, Yue Z.
europepmc   +1 more source

Prevention of Myc‐Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane

Molecular Carcinogenesis, Volume 65, Issue 9, Page 1052-1062, September 2026.
ABSTRACT Prevention is desirable to reduce suffering and death from prostate cancer. However, a clinical‐grade intervention for the prevention of this malignancy is still lacking. This study was undertaken to determine the feasibility of prostate cancer prevention by broccoli constituent sulforaphane (SFN) because epidemiological studies have suggested
Krishna B. Singh, Eun‐Ryeong Hahm, Bruce L. Jacobs, Shivendra V. Singh   +3 more
wiley   +1 more source

Cognitive function in patients undergoing robotic radical prostatectomy - 1 year follow up. [PDF]

J Robot Surg
Popiołek A, Brzoszczyk B, Borowczak J, Bitner-Szulc J, Popławska J, Jarzemski P, Borkowska A, Bieliński M.   +7 more
europepmc   +1 more source

Cancer Neuroscience: From Local Neuro–Immune Microenvironments to Systemic Brain–Body Circuitry

MedComm, Volume 7, Issue 9, September 2026.
This review outlines the cancer neuroscience paradigm, spanning systemic brain–body circuitry and local neuro–immune–tumor microenvironments. We discuss how tumors promote axonogenesis and pseudo‐synapse formation, and how sensory neuropeptides, such as CGRP, contribute to CD8+ T‐cell exhaustion.
Mingxuan Xie, Yu Zhao, Xinruo Xing, Yuqiang Liu, Jungang Zhao, Maojin Yao, Jun Tang, Jianzhu Zhao   +7 more
wiley   +1 more source

Retrograde robot-assisted radical prostatectomy in a patient with localized prostate cancer: a case report. [PDF]

Front Surg
Harizanova Z, Ahmed-Popova F, Pavlov V, Bozhikova E.   +3 more
europepmc   +1 more source

Prostate Cancer Development, Progression, and Therapy

MedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides an integrated overview of prostate cancer development, progression, and therapy, spanning historical milestones, molecular mechanisms, advanced research models, and emerging therapeutic strategies. It highlights recent advances in precision diagnosis, lineage plasticity, therapy resistance, and next‐generation treatments for ...
Xin Jin, Zicheng Xiao, Zexian Ding, Wei Li, Ruijiang Zeng, Yujun Shuai, Weimin Ci, Dan Xia, Xu Zhang, Haojie Huang   +9 more
wiley   +1 more source